Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, Quesada Gomez JM. Entrenas Castillo M, et al. Among authors: entrenas costa lm. J Steroid Biochem Mol Biol. 2020 Oct;203:105751. doi: 10.1016/j.jsbmb.2020.105751. Epub 2020 Aug 29. J Steroid Biochem Mol Biol. 2020. PMID: 32871238 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 32448555
Response to the GEMA Executive Committee.
Entrenas Costa LM, Entrenas Castillo M. Entrenas Costa LM, et al. Arch Bronconeumol. 2020 Jul;56(7):473. doi: 10.1016/j.arbr.2020.03.010. Epub 2020 Jun 12. Arch Bronconeumol. 2020. PMID: 35373762 No abstract available.
Calcifediol for Use in Treatment of Respiratory Disease.
Entrenas-Castillo M, Salinero-González L, Entrenas-Costa LM, Andújar-Espinosa R. Entrenas-Castillo M, et al. Among authors: entrenas costa lm. Nutrients. 2022 Jun 13;14(12):2447. doi: 10.3390/nu14122447. Nutrients. 2022. PMID: 35745177 Free PMC article. Review.
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.
Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ. Pérez de Llano LA, et al. Among authors: entrenas costa lm. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017. Epub 2019 Jan 21. J Allergy Clin Immunol Pract. 2019. PMID: 30677539 Free article. Clinical Trial.
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study.
Entrenas Costa LM, Casas-Maldonado F, Soto Campos JG, Padilla-Galo A, Levy A, Álvarez Gutiérrez FJ, Gómez-Bastero Fernández AP, Morales-García C, Gallego Domínguez R, Villegas Sánchez G, Mateos Caballero L, Pereira-Vega A, García Polo C, Pérez Chica G, Martín Villasclaras JJ. Entrenas Costa LM, et al. Pharmacoecon Open. 2019 Sep;3(3):333-342. doi: 10.1007/s41669-019-0117-4. Pharmacoecon Open. 2019. PMID: 30684255 Free PMC article.
Guidelines for the study of nonspecific bronchial hyperresponsiveness in asthma. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
Perpiñá Tordera M, García Río F, Álvarez Gutierrez FJ, Cisneros Serrano C, Compte Torrero L, Entrenas Costa LM, Melero Moreno C, Rodríguez Nieto MJ, Torrego Fernández A; Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Perpiñá Tordera M, et al. Among authors: entrenas costa lm. Arch Bronconeumol. 2013 Oct;49(10):432-46. doi: 10.1016/j.arbres.2013.05.001. Epub 2013 Jul 26. Arch Bronconeumol. 2013. PMID: 23896599 English, Spanish. No abstract available.
13 results